LAURA COX: Open Payments
NPI 1902234289 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 76 payments from 17 companies in 2025. Trend: 2023 $1,563 · 2024 $877 · 2025 $1,336
Food & beverage: $1,319Education: $17
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 21 | $226 |
| GlaxoSmithKline, LLC. | 11 | $220 |
| GENZYME CORPORATION | 11 | $195 |
| Verona Pharma, Inc. | 9 | $194 |
| Grifols USA, LLC | 5 | $114 |
| JAZZ PHARMACEUTICALS INC. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Electromed, Inc. | 2 | $43 |
| HARMONY BIOSCIENCES LLC | 1 | $27 |
Products named: DUPIXENT, Ohtuvayre, TRELEGY ELLIPTA, Prolastin-C Liquid, NUCALA, XYWAV, SMARTVEST, FASENRA.
Industry payments across TX — which companies pay providers there.
